CHRISTOPHER J. WILLIAMS - 31 Mar 2025 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
31 Mar 2025
Transactions value $
$0
Form type
4
Filing time
02 Apr 2025, 16:17:48 UTC
Previous filing
05 Feb 2025
Next filing
02 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +151 +0.82% $0 18,409 14 Feb 2025 Common Stock 150 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +221 +1.2% $0 18,630 31 Mar 2025 Common Stock 220 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.